845 related articles for article (PubMed ID: 8227362)
1. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
3. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets.
Turini ME; Holub BJ
Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
[TBL] [Abstract][Full Text] [Related]
5. Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.
Mitsui T; Yokoyama S; Shimizu Y; Katsuura M; Akiba K; Hayasaka K
Thromb Haemost; 1997 May; 77(5):991-5. PubMed ID: 9184416
[TBL] [Abstract][Full Text] [Related]
6. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
7. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane A2/prostaglandin H2 receptors.
Knezevic I; Borg C; Le Breton GC
J Biol Chem; 1993 Dec; 268(34):26011-7. PubMed ID: 8245033
[TBL] [Abstract][Full Text] [Related]
8. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
9. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
[TBL] [Abstract][Full Text] [Related]
10. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
Okwu AK; Mais DE; Halushka PV
Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
[TBL] [Abstract][Full Text] [Related]
12. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
[TBL] [Abstract][Full Text] [Related]
13. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
14. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
17. Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation.
Fuse I; Mito M; Hattori A; Higuchi W; Shibata A; Ushikubi F; Okuma M; Yahata K
Blood; 1993 Feb; 81(4):994-1000. PubMed ID: 8428006
[TBL] [Abstract][Full Text] [Related]
18. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
Kinsella BT; O'Mahony DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
[TBL] [Abstract][Full Text] [Related]
19. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
Hanasaki K; Arita H
Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
[TBL] [Abstract][Full Text] [Related]
20. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
Masuda A; Mais DE; Oatis JE; Halushka PV
Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
